Timm-H. Jessen Appointed Managing Director
Cutanos GmbH announces a leadership transition as co-founder and CEO Dr. Robert Wawrzinek takes a break steps down from his role for personal reasons. Dr. Wawrzinek will continue to support the company as a board member and strategic advisor. The Board has appointed Dr. Timm-H. Jessen as interim Managing Director.
—
Publication – Frontiers in Immunology
Specific Protein Antigen Delivery to Human Langerhans Cells in Intact Skin — Mareike Rentzsch, Robert Wawrzinek, Claudia Zelle-Rieser, Helen Strandt, Lydia Bellmann, Felix F. Fuchsberger, Jessica Schulze, Jil Busmann, Juliane Rademacher, Stephan Sigl, Barbara Del...
Webinar Series
Precision NanoSystems Teatime Webinar Series — Robert Wawrzinek talks about: "Small Molecule-Based Targeted Delivery of Nanoparticles to Langerhans Cells in Human Skin"
Publication – ACS central science
A Specific, Glycomimetic Langerin Ligand for Human Langerhans Cell Targeting — Eike-Christian Wamhoff, Jessica Schulze, Lydia Bellmann, Mareike Rentzsch, Gunnar Bachem, Felix F. Fuchsberger, Juliane Rademacher, Martin Hermann, Barbara Del Frari, Rob van Dalen, David...
Publication – Biochemistry
A Liposomal Platform for Delivery of a Protein Antigen to Langerin-Expressing Cells — Jessica Schulze, Mareike Rentzsch, Donyoon Kim, Lydia Bellmann, Patrizia Stoitzner, Christoph Rademacher Biochemistry (2019), doi.org/10.1021/acs.biochem.9b0040
Press Coverage
what the media says about Cutanos (selection)